Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Heidelberg Innovation was founded in 1997 in Heidelberg, Germany, with the mission to support the commercialization of research and innovation. The organization focused on bridging the gap between academia and industry, particularly in the life sciences sector. Over the years, it became known for its early-stage investments in technology companies emerging from academic research, primarily within the German market.
Managing total assets of €125 million across three funds, Heidelberg Innovation played a significant role in the venture capital landscape, particularly in the life sciences domain. The firm’s portfolio included several notable technology-driven startups, showcasing its commitment to fostering innovation in healthcare and medical technology. Although the firm has been described in the past tense, its historical contributions to the sector remain relevant for understanding the evolution of venture capital in Germany.
Heidelberg Innovation historically invested in early-stage technology companies, with a strong emphasis on the life sciences, medical technology, and healthcare sectors. The firm targeted investments at various stages, including pre-seed, seed, seed-plus, Series A, Series B, Series C, and growth equity. This broad stage focus allowed them to engage with startups at different points in their development, providing essential support tailored to their needs.
The organization primarily operated within the German market, seeking opportunities that emerged from local universities and research institutions. Their investment strategy emphasized fostering innovation and supporting startups that could bridge the gap between academic research and commercial viability. This focus on life sciences positioned Heidelberg Innovation as a sector-specialist investor, dedicated to advancing medical technology and healthcare solutions.
Heidelberg Innovation's portfolio included several notable technology-driven startups, particularly in the life sciences sector. Key companies in their portfolio included:
These companies exemplify Heidelberg Innovation's commitment to supporting technology-driven startups that address critical challenges in healthcare and medical technology.
Dr. Thomas Müller - Managing Director. Dr. Müller has extensive experience in venture capital and life sciences, having led numerous investments in technology companies. His background includes a strong academic foundation in biomedical sciences.
Dr. Anna Schmidt - Project Manager. Dr. Schmidt specializes in supporting startups in the healthcare sector, leveraging her expertise in medical technology and innovation management.
Michael Becker - Business Development Manager. Becker focuses on identifying new investment opportunities and fostering relationships with portfolio companies, drawing on his background in business development within the life sciences.
To pitch Heidelberg Innovation, interested parties should visit their website at hd-innovation.de. While specific application forms or portals were not detailed, the website serves as the primary channel for submissions. Founders should prepare a comprehensive pitch deck that outlines their business model, market opportunity, and the scientific basis for their innovations. Response times may vary, and a warm introduction through academic or industry connections could enhance the chances of engagement.
Heidelberg Innovation has been described in various sources as a historical venture capital firm focused on life sciences. Recent activity signals indicate that the firm is likely defunct, with no new investments or updates reported since the mid-2000s. The last known significant activity was in 2005, with a focus on supporting startups emerging from academic research.
As of 2026, the official website appears inactive, and third-party sources confirm that Heidelberg Innovation is no longer actively investing. Founders should treat this profile as a historical reference rather than a current funding target.
What are Heidelberg Innovation's investment criteria?
Heidelberg Innovation focused on early-stage technology companies, particularly those in the life sciences, medical technology, and healthcare sectors. They sought startups that originated from academic research and demonstrated potential for commercialization.
How can I pitch to Heidelberg Innovation?
Interested parties can submit their pitches through the official website at hd-innovation.de. While specific email addresses were not provided, the website serves as the primary channel for applications.
What makes Heidelberg Innovation different from other VCs?
The firm specialized in bridging the gap between academia and industry, leveraging strong connections with local universities and research institutions. This unique positioning allowed them to identify and support innovative startups emerging from academic research.
What is the geographic focus of Heidelberg Innovation?
Heidelberg Innovation primarily operated within the German market, although they also had historical activity in Western Europe, including Switzerland and the United States.
What is the typical check size for investments?
While specific check sizes were not disclosed, historical data suggests that deal sizes ranged from USD 10 million to USD 50 million, indicating a significant commitment to their portfolio companies.
What kind of support do portfolio companies receive?
Heidelberg Innovation aimed to add value to its portfolio companies by providing strategic guidance, facilitating access to resources necessary for commercialization, and leveraging connections within academia and industry.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.